Brief: Organogenesis Posts Q4 net income USD 7.5 million
Mar 1 (Reuters) - Organogenesis Q4 net income USD 7.5 million. * Q4 operating income USD 8.7 million * Q4 revenue USD 115.5 million * Q4 adjusted net income USD 8.9 million * Q4 adjusted EBITDA USD 14.1 million * Outlook FY net income USD 7.2-13.9 million * Outlook FY EBITDA USD 26.6-36.1 million * Outlook FY adjusted net income USD 12.3-19 million * Outlook FY adjusted EBITDA USD 36.5-46 million
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers